Skip to main content
颖泰生物 logo

颖泰生物 - Investor Relations & Filings

Listed IPO May 2024
Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2025-10-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
关于新增2025年度日常性关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the addition of expected daily related-party transactions for the fiscal year 2025 by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the nature, amounts, counterparties, and approval process of these related-party transactions. The document includes financial figures, descriptions of related parties, and board resolutions approving the transactions. It is not a full financial report, audit report, or earnings release, but rather a regulatory announcement about related-party transactions. This type of document fits best under the category of Regulatory Filings (RNS), as it is a compliance disclosure about related-party transactions and board approvals, without substantive financial statements or detailed financial analysis typical of other report types.
2025-10-23 Chinese
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on September 12, 2025, including participants, questions asked, and answers given about the company's market, products, projects, industry trends, and capital operation plans. The document is relatively short (1698 characters) and does not contain financial statements or detailed financial data. It is a record of an investor relations meeting rather than a formal financial report or earnings release. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update directly. It is also not a presentation or transcript of a conference call. Given the nature of the document as a record of investor relations activities, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories.
2025-09-15 Chinese
北京市康达律师事务所关于北京颖泰嘉和生物科技股份有限公司2025年第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, qualifications of participants, and voting results of the 2025 first extraordinary shareholders' meeting of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes detailed voting results on various resolutions and confirms the legality and validity of the meeting process and outcomes. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholders' meeting and its resolutions. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting.
2025-09-02 Chinese
2025年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 first extraordinary shareholders meeting of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes voting results for multiple proposals, attendance details, legal compliance statements, and personnel changes effective from the meeting. The content focuses on the official results of shareholder votes and meeting decisions rather than presenting financial data or management discussion. The document length is 4275 characters, which is relatively short but contains substantive voting results and resolutions, not just a notice of report publication. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-09-02 Chinese
内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system regarding the registration and management of insiders with access to material non-public information (insider information) at Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes rules on insider information definition, insider registration, confidentiality, and responsibilities. The document is a formal announcement of an internal governance policy approved by the board of directors. It does not contain financial statements, earnings data, or audit results. It is not a report of financial performance or an announcement of voting results. It is a governance-related document detailing internal rules and procedures for compliance with securities laws and insider information management. Therefore, it fits best under Governance Information (CGR). The document length (7703 characters) and content confirm it is the policy document itself, not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2025-08-14 Chinese
第四届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 4th Board of Directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other announcements and documents disclosed on the Beijing Stock Exchange platform. The content focuses on board decisions, internal management system revisions, and governance matters such as the cancellation of the supervisory board and amendments to the company charter. There is no actual financial data or full financial report included; rather, it is a formal disclosure of board meeting resolutions and governance-related decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management.
2025-08-14 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.